Brief: Medacta Group says Initiation Of Commercial Use Of 3Dmetaltm Femoral Cones For Revision Knee Arthroplasty After Receiving Clearance From FDA & CE Marking
Sept 29 (Reuters) - Medacta Group SA MOVE.S :
* MEDACTA GROUP - INITIATION OF COMMERCIAL USE OF 3DMETALTM
FEMORAL CONES FOR REVISION KNEE ARTHROPLASTY AFTER RECEIVING
CLEARANCE FROM FDA & CE MARKING
Source text for Eikon: ID:
Further company coverage: MOVE.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medacta SA
See all newsBrief: Medacta Group Updates 2026 Guidance, Reiterates 2024-2027 Mid-Term Outlook
Swiss medical device maker Medacta H1 revenue rises on Asia Pacific, EMEA strength
Brief: Medacta H1 Adjusted EBITDA EUR 97 Million
Switzerland's Medacta H1 revenue rises 9.7% in constant currency
Brief: Medacta H1 Revenue EUR 368 Million